William James Garner, Director at InMed Pharmaceuticals, holds 0.00 shares in InMed Pharmaceuticals (Ticker: INM), holds 50.63M shares in GeneTether Therapeutics, Inc. (Ticker: TSE:RIZE), holds 38.42M shares in Tryp Therapeutics Inc (Ticker: TSE:TRYP). Most recently, William James Garner ― shares of InMed Pharmaceuticals on ― for an estimated value of ―.
What is the percentage of profitable transactions made by William James Garner?
The percentage of profitable transactions made by William James Garner is 38%.
What is the average return per transaction made by William James Garner?
The average return per transaction made by William James Garner is -60.00%.
What stocks does William James Garner hold?
William James Garner holds: INM, TSE:TRYP, AU:RAC, IVIXF, TSE:RIZE stocks.
What was William James Garner’s latest transaction?
William James Garner latest transaction was an Uninformative Buy of ―.
What was William James Garner's most profitable transaction?
William James Garner’s most profitable transaction was an Informative Buy of AU:RAC stock on October 14, 2019. The return on the trade was 144.80%.
What is William James Garner's role in InMed Pharmaceuticals?
William James Garner's role in InMed Pharmaceuticals is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.